Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Polycystic Ovary Syndrome 1Ovarian Hyperstimulation Syndrome 1

Interventions

Triptorelin Pamoate 4Diet, Mediterranean 2Chorionic Gonadotropin 2ganirelix 1follicle stimulating hormone, human, with HCG C-terminal peptide 1cinnulin PF 1cetrorelix 1Thioctic Acid 1Surveys and Questionnaires 1Profasi 1Positron-Emission Tomography 1Pentoxifylline 1Menotropins 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Gonadotropins 1Clomiphene 1Cabergoline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Profasi × Gynecologic × Clear all
NCT01815138 2018-10-26

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

UConn Health

Phase 4 Completed
89 enrolled 13 charts
Gynecologic

Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡